|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/10 | (2006.01) |
| A61P 25/28 | (2018.01) | ||
| A61K 31/275 | (2006.01) | ||
| A61K 31/275 | (2013.01) | ||
| A61P 25/28 | (2006.01) | ||
| A61K 9/0019 | (2013.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61K 9/0053 | (2013.01) | ||
| A61K 9/008 | (2013.01) |
| (11) | Patento numeris | 3746057 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 19746676.6 |
| Europos patento paraiškos padavimo data | 2019-01-31 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-12-09 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-03-20 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2019/016012 |
| Data | 2019-01-31 |
| (87) | Numeris | WO 2019/152627 |
| Data | 2019-08-08 |
| (30) | Numeris | Data | Šalis |
| 201862624637 P | 2018-01-31 | US |
| (72) |
DINARELLO, Charles A. , US
|
| (73) |
Olatec Therapeutics, Inc. ,
800 Fifth Avenue, 25 Floor, New York, NY 10065,
US
|
| (54) | DAPANSUTRILE FOR PREVENTING OR TREATING ALZHEIMER'S DISEASE |
| DAPANSUTRILE FOR PREVENTING OR TREATING ALZHEIMER'S DISEASE |